Efficacy and safety of nalfurafine hydrochloride for pruritus in patients with chronic liver disease in Japan

被引：0
|
作者：
Kawano, Tadamichi [1 ]
Atsukawa, Masanori [1 ]
Tsubota, Akihito [2 ]
Shioda, Kaori [1 ]
Ono, Hiroki [1 ]
Okubo, Tomomi [1 ]
Arai, Taeang [1 ]
Hayama, Korenobu [1 ]
Kaneko, Keiko [1 ]
Itokawa, Norio [1 ]
Iwakiri, Katsuhiko [1 ]
机构：
[1] Nippon Med Sch, Div Gastroenterol & Hepatol, Tokyo, Japan
[2] Jikei Univ, Core Res Facil, Sch Med, Tokyo, Japan
来源：
JOURNAL OF HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
WED-327
引用
收藏
页码：S240 / S241
页数：2
相关论文
共 50 条
  • [1] Pruritus is common in patients with chronic liver disease and is improved by nalfurafine hydrochloride
    Shuhei Yoshikawa
    Takeharu Asano
    Mina Morino
    Keita Matsumoto
    Hitomi Kashima
    Yudai Koito
    Takaya Miura
    Yuko Takahashi
    Rumiko Tsuboi
    Takehiro Ishii
    Haruka Otake
    Junichi Fujiwara
    Masanari Sekine
    Takeshi Uehara
    Kazuhito Yuhashi
    Satohiro Matsumoto
    Shinichi Asabe
    Hiroyuki Miyatani
    Hirosato Mashima
    Scientific Reports, 11
  • [2] Pruritus is common in patients with chronic liver disease and is improved by nalfurafine hydrochloride
    Yoshikawa, Shuhei
    Asano, Takeharu
    Morino, Mina
    Matsumoto, Keita
    Kashima, Hitomi
    Koito, Yudai
    Miura, Takaya
    Takahashi, Yuko
    Tsuboi, Rumiko
    Ishii, Takehiro
    Otake, Haruka
    Fujiwara, Junichi
    Sekine, Masanari
    Uehara, Takeshi
    Yuhashi, Kazuhito
    Matsumoto, Satohiro
    Asabe, Shinichi
    Miyatani, Hiroyuki
    Mashima, Hirosato
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [3] Predictors of pruritus in patients with chronic liver disease and usefulness of nalfurafine hydrochloride
    Akuta, Norio
    Kumada, Hiromitsu
    Fujiyama, Shunichiro
    Kawamura, Yusuke
    Sezaki, Hitomi
    Hosaka, Tetsuya
    Kobayashi, Masahiro
    Kobayashi, Mariko
    Saitoh, Satoshi
    Suzuki, Yoshiyuki
    Suzuki, Fumitaka
    Arase, Yasuji
    Ikeda, Kenji
    HEPATOLOGY RESEARCH, 2018, 48 (01) : 45 - 50
  • [4] Efficacy of nalfurafine hydrochloride in patients with chronic liver disease with refractory pruritus: A randomized, double-blind trial
    Kumada, Hiromitsu
    Miyakawa, Hiroshi
    Muramatsu, Taro
    Ando, Naoki
    Oh, Takanori
    Takamori, Kenji
    Nakamoto, Hidetomo
    HEPATOLOGY RESEARCH, 2017, 47 (10) : 972 - 982
  • [5] Long-term efficacy and safety of nalfurafine hydrochloride on pruritus in chronic liver disease patients: Patient-reported outcome based analyses
    Kamimura, Kenya
    Yokoo, Takeshi
    Kamimura, Hiroteru
    Sakamaki, Akira
    Abe, Satoshi
    Tsuchiya, Atsunori
    Takamura, Masaaki
    Kawai, Hirokazu
    Yamagiwa, Satoshi
    Terai, Shuji
    PLOS ONE, 2017, 12 (06):
  • [6] Shorter pruritus period and milder disease stage are associated with response to nalfurafine hydrochloride in patients with chronic liver disease
    Tadamichi Kawano
    Masanori Atsukawa
    Akihito Tsubota
    Noritomo Shimada
    Hidenori Toyoda
    Koichi Takaguchi
    Joji Tani
    Asahiro Morishita
    Atsushi Hiraoka
    Shigeru Mikami
    Toru Ishikawa
    Hironao Okubo
    Tsunamasa Watanabe
    Tomomi Okubo
    Taeang Arai
    Korenobu Hayama
    Norio Itokawa
    Chisa Kondo
    Katsuhiko Iwakiri
    Scientific Reports, 12
  • [7] Shorter pruritus period and milder disease stage are associated with response to nalfurafine hydrochloride in patients with chronic liver disease
    Kawano, Tadamichi
    Atsukawa, Masanori
    Tsubota, Akihito
    Shimada, Noritomo
    Toyoda, Hidenori
    Takaguchi, Koichi
    Tani, Joji
    Morishita, Asahiro
    Hiraoka, Atsushi
    Mikami, Shigeru
    Ishikawa, Toru
    Okubo, Hironao
    Watanabe, Tsunamasa
    Okubo, Tomomi
    Arai, Taeang
    Hayama, Korenobu
    Itokawa, Norio
    Kondo, Chisa
    Iwakiri, Katsuhiko
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [8] Recurrence rates of pruritus after the stop of nalfurafine hydrochloride in chronic liver disease: Preliminary prospective confirmatory trial
    Akuta, Norio
    Kumada, Hiromitsu
    Fujiyama, Shunichiro
    Kawamura, Yusuke
    Sezaki, Hitomi
    Hosaka, Tetsuya
    Kobayashi, Masahiro
    Kobayashi, Mariko
    Saitoh, Satoshi
    Suzuki, Yoshiyuki
    Suzuki, Fumitaka
    Arase, Yasuji
    Ikeda, Kenji
    HEPATOLOGY RESEARCH, 2018, 48 (10) : 810 - 813
  • [9] Effect of nalfurafine hydrochloride on pruritus and anxiety level in hemodialysis patients
    Inui, Shigeki
    Shirakawa, Yuko
    Itami, Satoshi
    JOURNAL OF DERMATOLOGY, 2012, 39 (10): : 886 - 887
  • [10] EFFECT OF A NOVEL KAPPA-RECEPTOR AGONIST, NALFURAFINE HYDROCHLORIDE, ON PATIENTS WITH CHRONIC LIVER DISEASE
    Okamoto, Norio
    Fukunishi, Shinya
    Asai, Akira
    Higuchi, Kazuhide
    GASTROENTEROLOGY, 2018, 154 (06) : S535 - S535
12345